methylprednisolone and Typhoid Fever

methylprednisolone has been researched along with Typhoid Fever in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aznar, J; Falcón-Neyra, L; Lucena, JM; Neth, O; Olbrich, P; Sánchez-Moreno, P1
Basnyat, B; Kayastha, G; Mittal, N; Thapa, A1
Ajao, A; Ajao, OG; Johnson, T1

Reviews

1 review(s) available for methylprednisolone and Typhoid Fever

ArticleYear
Typhoid fever causing haemophagocytic lymphohistiocytosis in a non-endemic country - first case report and review of the current literature.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:2

    Topics: Abdominal Abscess; Abdominal Pain; Age Distribution; Appendicitis; Asia; Ceftriaxone; Child; Developed Countries; Diagnosis, Differential; Endemic Diseases; Fever; Hepatomegaly; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Middle East; Sex Distribution; Spain; Splenomegaly; Typhoid Fever

2019

Trials

1 trial(s) available for methylprednisolone and Typhoid Fever

ArticleYear
Methylprednisolone sodium succinate (Solu-Medrol) in the treatment of typhoid perforation (a preliminary report).
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 1984, Volume: 78, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Ileal Diseases; Intestinal Perforation; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Random Allocation; Sepsis; Shock, Septic; Typhoid Fever

1984

Other Studies

1 other study(ies) available for methylprednisolone and Typhoid Fever

ArticleYear
Typhoid fever with isolated left lateral rectus palsy.
    BMJ case reports, 2018, Sep-04, Volume: 2018

    Topics: Abducens Nerve Diseases; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Diplopia; Female; Humans; Methylprednisolone; Neuroprotective Agents; Typhoid Fever

2018